Boston Scientific Corp (NYSE:BSX)
| 39.22 Delayed Data As of May 20 |  -0.27 / -0.68%Today’s Change | 37.96 Today|||52-Week Range 47.50 | -7.67% Year-to-Date |
Latest BSX News | Press Releases
| BRADLEY FOSTER & SARGENT INC/CT Buys 2, Sells 3 in 1st Quarter May 18 / GuruFocus News - Paid Partner Content | Top Analyst Reports for Adobe, Danaher, Equinor & Others May 09 / Zacks.com - Paid Partner Content |
Today’s Trading
| Previous close | 39.49 |
| Today’s open | 39.45 |
| Day’s range | 38.25 - 39.53 |
| Volume | 12,397,592 |
| Average volume (3 months) | 9,355,585 |
| Market cap | $56.1B |
Data as of 4:04pm ET, 05/20/2022
Growth & Valuation
| Earnings growth (last year) | -- |
| Earnings growth (this year) | +8.31% |
| Earnings growth (next 5 years) | +11.00% |
| Revenue growth (last year) | +19.92% |
| P/E ratio | 74.0 |
| Price/Sales | 5.12 |
| Price/Book | 3.36 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| BDXBecton Dickinson and... | +1.10 | +0.44% |
| BAXBaxter International... | +0.63 | +0.87% |
| DXCMDexcom Inc | +5.03 | +1.59% |
| ZBHZimmer Biomet Holdin... | +0.70 | +0.60% |
Data as of 4:35pm ET, 05/20/2022
Financials
| Next reporting date | July 27, 2022 |
| EPS forecast (this quarter) | $0.43 |
| Annual revenue (last year) | $11.9B |
| Annual profit (last year) | $1.0B |
| Net profit margin | 8.75% |
Profile
Sector Health Technology |
Industry Medical Specialties |
No executives to display |
Corporate headquarters Marlborough, Massachusetts |
Forecasts
